Sunday, May 9, 2021
Entera Bio, Ltd. (NASDAQ: ENTX) Skyrockets 242% After Its Phase 2 Biomarker Data of EB613 Met Primary Endpoint
Entera Bio, Ltd. (NASDAQ: ENTX) is a global leader in the research and development of orally-delivered large molecule therapeutics across...
Read more
Second Sight Medical Products, Inc. (NASDAQ: EYES) Skyrockets 156% After its Argus 2s Retinal Prosthesis System is Approved By FDA
Second Sight Medical Products, Inc. (NASDAQ: EYES) is engaged within the research, development, and marketing of implantable visual prosthetics. The...
Read more
Five Prime Therapeutics, Inc. (NASDAQ: FPRX) Soars 78% After Agreeing to be Acquired by Amgen (NASDAQ: AMGN) for $1.9 Billion
Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is engaged as a clinical stage biotechnology company that is focused on developing novel...
Read more
Entera Bio, Ltd. (NASDAQ: ENTX) Skyrockets 242% After Its Phase 2 Biomarker Data of EB613 Met Primary Endpoint
Entera Bio, Ltd. (NASDAQ: ENTX) is a global leader in the research and development of orally-delivered large molecule therapeutics across...
Read more
Second Sight Medical Products, Inc. (NASDAQ: EYES) Skyrockets 156% After its Argus 2s Retinal Prosthesis System is Approved By FDA
Second Sight Medical Products, Inc. (NASDAQ: EYES) is engaged within the research, development, and marketing of implantable visual prosthetics. The...
Read more
Five Prime Therapeutics, Inc. (NASDAQ: FPRX) Soars 78% After Agreeing to be Acquired by Amgen (NASDAQ: AMGN) for $1.9 Billion
Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is engaged as a clinical stage biotechnology company that is focused on developing novel...
Read more
Bio-Path Holdings, Inc. (NASDAQ: BPTH) Soars 242% After Receiving Third Patent for its DNAbilize Platform Technology
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is engaged as a biotechnology company, which is focused on the research and development of...
Read more
Ocugen, Inc. (NASDAQ: OCGN) Skyrockets 122% After $23 Million Registered Direct Offering at a Premium to Market Price
Ocugen, Inc. (NASDAQ: OCGN) operates as a biopharmaceutical company focused on the research, discovery, development, and commercialization of gene therapies....
Read more
GeoVax Labs, Inc. (NASDAQ: GOVX) Surges 93% After Receiving NIH Grant to Advance COVID-19 Vaccine
GeoVax Labs, Inc. (NASDAQ: GOVX) is engaged as a clinical-stage biotech company, which is focused on developing novel vaccines to...
Read more
Ocugen, Inc. (NASDAQ: OCGN) Skyrockets 148% After Announcing Partnership to Co-Develop Covaxin, an Inactivated COVID-19 Vaccine Candidate
Ocugen, Inc. (NASDAQ: OCGN) is engaged as a biopharmaceutical company, which is primarily focused on the research, development, and commercialization...
Read more
